STICE et al. V. STICE et al. V. STRELCHENKO et al. V. HENSEN et al. - Page 26





                                          Therefore, the "reprogrammed cell [that] is totipotent" as claimed by                                        
                                  Strelchenko in Claim 106 of the '445 Application as it was filed on July 20.                                         
                                  1999, is substantially the same subject matter as the "proliferating somatic                                         
                                  cell that has been expanded in culture" as claimed by Stice in Claim I of the                                        
                                  '577 patent.                                                                                                         
                Paper 50, pp. 22-23, citations to exhibits deleted.                                                                                    
                         Strelchenko Claim 107 depended from Claim 106 and added the requirement that the non                                          
                embryonic cells be "reprogrammed by cultivation in a culture medium." As a dependent claim,                                            
                Claim 107 incorporates by reference all the limitations of the claim from which it depends. 35                                         
                U.S.C. § 112,12. Strelchenko, inter alia, repeats the same argument that the use of a totipotent cell                                  
                and a somatic cell that has been expanded in culture are substantially the same. Thus, Strelchenko                                     
                states:                                                                                                                                
                                  Claim 107 is directed to substantially the same subject matter as the invention                                      
                                  claimed by Stice in Claim 12 of the '577 patent. Claim 107 specifies that the                                        
                                  "reprogrammed cell is totipotent," meaning capable of developing into an                                             
                                  organism. Claim 107 further specifies that the "reprogramming" is achieved                                           
                                  by culturing the cells under conditions which will create proliferating cells.                                       
                                  Given the definitions of totipotent and somatic cell given in the '445                                               
                                  Application and the Glossary, a "totipotent cell" obtained by culturing a non                                        
                                  embryonic cell, as claimed in Claim 107 of the '445 Application is                                                   
                                  substantially the same as a "proliferating somatic cell" claimed by Stice as                                         
                                  being able to generate an embryo (capable of developing into an organism).                                           
                                          Therefore, the "reprogrammed" totipotent cell that is "reprogrammed                                          
                                  by cultivation in a culture medium" as claimed by Strelchenko in Claim 107                                           
                                  of the '445 Application as it was filed on July 20, 1999, is substantially the                                       
                                  same subject matter as the "proliferating somatic cell that has been expanded                                        
                                  in culture" as claimed by Stice in Claim I of the '577 patent.                                                       
                Paper 50, pp. 23-24.                                                                                                                   
                         In support of this argument, Strelchenko relies on the testimony of Dr. Eric Forsberg. Dr.                                    
                Forsberg testifies:                                                                                                                    

                                  5. Most of the cells of mammals have a number of copies of each                                                      
                                  chromosome, referred to as the "ploidy" of the cell.                                                                 
                                  6. The gametes of mammals are haploid having but a single copy of each                                               
                                  chromosome.                                                                                                          

                                                                       -26-                                                                            








Page:  Previous  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  Next 

Last modified: November 3, 2007